Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Kyle, S. Rajkumar (2009)
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myelomaLeukemia, 23
Vanessa Bitelman, Josélia Lopes, A. Nogueira, F. Frassetto, A. Duarte-Neto (2016)
“Punched out” multiple myeloma lytic lesions in the skullAutopsy & Case Reports, 6
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s)
Robert Kyle, M. Gertz, T. Witzig, J. Lust, M. Lacy, A. Dispenzieri, R. Fonseca, S. Rajkumar, J. Offord, Dirk Larson, Matthew Plevak, Terry Therneau, P. Greipp (2003)
Review of 1027 patients with newly diagnosed multiple myeloma.Mayo Clinic proceedings, 78 1
(2017)
Clinico-hematological profile of multiple myeloma in tertiary care
P. Kaur, B. Shah, P. Baja (2014)
Multiple myeloma: a clinical and pathological profile.The Gulf journal of oncology, 1 16
N. Shinton (2007)
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
R. Kaushik, R. Thakur, Anchana Gulati, Sudarshan Sharma (2017)
Multiple Myeloma: Clinico-hematological profile in a tertiary care hospital: a three years study.Annals of Pathology and Laboratory Medicine, 4
R. Kapoor, M. Bansal, G. Sastri, Sandhu, M. Garg, S. Sharma (2006)
Clinical Spectrum and Prognosis of Multiple Myeloma in Patients Younger than 30 Years : Is it Different from the Elderly ?
R. Kyle (1988)
Prognostic factors in multiple myelomaHematological Oncology, 6
Rajiv Subramanian, D. Basu, Tarun Dutta (2009)
Prognostic significance of bone marrow histology in multiple myeloma.Indian journal of cancer, 46 1
J. Kaplan (1976)
Multiple Myeloma in Young PersonsAnnals of Internal Medicine, 85
S. Paget (1989)
The distribution of secondary growths in cancer of the breast. 1889.Cancer metastasis reviews, 8 2
author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law
A. Diwan, Sushil Gandhi, K. Krishna, Vineet Shinde (2014)
Clinical profile of the spectrum of multiple myeloma in a teaching hospitalMedical Journal of Dr. D.Y. Patil University, 7
C. Blimark, E. Holmberg, U. Mellqvist, O. Landgren, M. Björkholm, M. Hultcrantz, C. Kjellander, I. Turesson, S. Kristinsson (2015)
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patientsHaematologica, 100
P. Lin, R. Owens, G. Tricot, Carla Wilson (2004)
Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.American journal of clinical pathology, 121 4
(2011)
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
The aim of the study was to evaluate the clinical and laboratory profile of newly diagnosed cases of Multiple myeloma (MM) in a tertiary care hospital in western India. Records of all the patients who were diagnosed as MM was taken out from the archives from September 2013 to February 2021 and analyzed for various parameters. Of the 100 patients studied, 3% were below the age of 40 years with most of the cases in the 6th and 7th decade. The mean age of the study was 61.98 years. The most common symptoms were low backache (LBA), bone pains and easy fatigability. Anemia was present at the outset in 67% of cases, hypercalcemia in 12% of cases, renal impairment in 22% of cases, raised lactate dehydrogenase (LDH) in 18% of cases and raised β2-microglobulin levels in 48% of cases. 37% of cases showed reversal of albumin:globulin (A:G) ratio. Bone marrow (BM) plasma cells (PC) ranged from 12 to 90% on myelogram. There was a detectable ‘monoclonal’ (M) spike in 77% of cases on serum protein electrophoresis whereas immunofixation revealed a monoclonal protein in 92% of cases. Osteolytic lesions were found in 64% of cases. Cytogenetic analysis showed cases to be harbouring del 13q, t(11;14), del 17p, immunoglobulin heavy chain (IGH) rearrangement and t(4;14). Most patients received a combination of the standard regimes of Bortezomib-Lenalidomide-Dexamethasone and the response was assessed at the end of each cycle. Plasma Cell Neoplasms (PCN) present with varied symptomatology and hence an extremely high index of suspicion is required for early diagnosis and prompt management.
Comparative Clinical Pathology – Springer Journals
Published: Dec 1, 2022
Keywords: Anemia; Bone marrow; Hematologic diseases; Plasma cell myeloma; Renal failure
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.